Call for Expressions of Interest
This CFI is part of the national Call for Projects "Tiers-Lieux d’Expérimentation en santé", operated by Caisse des Dépôts as part of the France 2030 program.
Per selected project
France 2030 grant covering up to 50% of eligible expenses.
No upfront payment.
One chance only in 2026
The national CFP only organizes one annual round for wave 3 TELs.
Deadline: June 10, 2026 at 6 PM.
As part of France 2030, the ‘Digital Health’ acceleration strategy aims to make France a leader in digital health innovation through significant investments. At the heart of this ambition, the Tiers-Lieux d’Expérimentation en santé (France 2030) funds real-world digital solution experiments.
submit up to 2 digital dermatology experimentation projects that are potentially eligible for funding. A selection committee will decide on the opportunity to fund or not the submitted projects
This CFI is part of the national Call for Projects “Tiers-Lieux d’Expérimentation en santé”, operated by Caisse des Dépôts as part of the France 2030 program.
Supported by the CHU de Nice and led by Prof. Thierry Passeron (Head of Dermatology, Head of Team 12 at the Mediterranean Center for Molecular Medicine), the Tiers-Lieux d’Expérimentation SKIN (TLE SKIN) is the first digital health experimentation third place exclusively dedicated to skin in France.
By relying on a consortium of multidisciplinary stakeholders, TLE SKIN offers comprehensive support from idea to market:
Cohort of dermatological patients: a diversified patient base at the Nice University Hospital and through the ADL/UGCA network, mobilizable for real-world clinical studies.
World-class expertise in AI, medical imaging, and dermatological clinical protocols, brought directly to the consortium.
The RESAH (Hospital Buyers Network) facilitates your access to the hospital market and the Eurobiomed competitiveness cluster supports your regulatory processes (CE marking, Medical Device...).
From structuring the application to leveraging results, TLE SKIN is an active partner.
The national call for projects is rich but dense. Here are the key points to consider before submitting your application.
The grant covers up to 250,000 € at 50% of your eligible expenses. It funds experimentation with the aim of improving and/or evaluating your solution. Therefore, it is not intended to equip the hospital for commercial purposes.
The call requires a technology readiness level of at least 4. Your solution must have been validated in the laboratory. Purely conceptual projects are not eligible. Solutions in pre-CE marking, post-marking or pre-marketing are all eligible.
Given the lead times involved in contractual arrangements, you should plan a 12- to 18-month pilot, with an effective start date by spring 2027 at the latest. Projects that are overly long or poorly calibrated in terms of timing are consistently penalized by the evaluation committee.
The national committee knows well the 106 projects already supported by TELs. Your added value must be explicitly demonstrated compared to what already exists. This is where TLE SKIN plays a key role: we help you position your solution in a differentiating way.
The committee evaluates the rigor with which TLE has selected your project. We document together the reasons why your solution was chosen. This is a concrete advantage of being supported by TLE SKIN.
The call requires, for each key indicator: the calculation method, the necessary cohort, the T0 value before use and the target value after use. This is a level of detail that many underestimate. We can help you formalize them.
Our commitment: the earlier you contact us, the better we can support you. We recommend a first exchange before the end of May 2026.
The TLE SKIN is open to all digital health stakeholders, startups, MedTechs, SMEs and ETIs or specialized laboratories, carrying a digital dermatology solution with a sufficient maturity level and a real clinical or organizational added value.
Our facilities are particularly suited to digital or hybrid solutions addressing:
Only one selection round is organized per year within this national CFP.
April – May 2026
First contact with TLE SKIN
Confidential preliminary exchange on the eligibility and positioning of your solution.
June 10, 2026
Closing of applications and pre-selection of projects
Interviews with selected applicants.
June 2026
Application co-construction
Structuring the application with the TLE SKIN team.
July 1, 2026
Selection of the best applications by the TLE SKIN Technical Committee
Selection of projects for this call. Non-selected projects will receive additional support if they wish.
July 10, 2026 → Deadline
Date limite
Submission of complete applications
Transmission to the national operator (Caisse des Dépôts). Mandatory deadline.
September 2026
Hearings before the France 2030 national committee
Video conference. Score out of 100 points. Opinion transmitted to CPMO for validation.
end of 2026
Notification & contracting
Prime Minister’s decision. Amendment to TLE SKIN’s France 2030 agreement.
2027 – 2028
Experiments in real conditions
Mandatory end: December 31, 2028. One selection round per year.
The official note of the national call for projects details all the evaluation criteria, the nature of eligible expenses, the application documents and the applicable regulatory framework.
For any question about the interpretation of the specifications with regard to your solution, contact us directly — it is precisely our role to help you navigate this framework.
